DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Yuen MF, Chen CY, Liu CJ. , et al.
Ascending dose cohort study of inarigivir - a novel RIG I agonist in chronic HBV patients: final results of the ACHIEVE trial.
J Hepatol 2019;
70: e47-e48
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.